Papillomavirus pseudovirions packaged with the L2 gene induce cross-neutralizing antibodies

Papillomavirus pseudovirions packaged with the L2 gene induce cross-neutralizing antibodies

<p>Abstract</p> <p>Background</p> <p>Current vaccines against HPVs are constituted of L1 protein self-assembled into virus-like particles (VLPs) and they have been shown to protect against natural HPV16 and HPV18 infections and associated lesions. In addition, limited c...

Full description

Bibliographic Details
Main Authors:	Duarte-Forero Diego F, Gaitan Julien, Ribeiro Tatiana, Fleury Maxime JJ, Saussereau Emilie, Combelas Nicolas, Coursaget Pierre, Touzé Antoine
Format:	Article
Language:	English
Published:	BMC 2010-03-01
Series:	Journal of Translational Medicine
Online Access:	http://www.translational-medicine.com/content/8/1/28

Similar Items

Development of a Triple-Color Pseudovirion-Based Assay to Detect Neutralizing Antibodies against Human Papillomavirus
by: Jianhui Nie, et al.
Published: (2016-04-01)

High-throughput pseudovirion-based neutralization assay for analysis of natural and vaccine-induced antibodies against human papillomaviruses.
by: Peter Sehr, et al.
Published: (2013-01-01)

Novel Production of Bovine Papillomavirus Pseudovirions in Tobacco Plants
by: Inge Pietersen, et al.
Published: (2020-11-01)

Construction and evaluation of human papillomavirus genotype 18 pseudovirions
by: H Sharifi, et al.
Published: (2015-11-01)

Measurement of Human Papillomavirus-Specific Antibodies Using a Pseudovirion-Based ELISA Method
by: Zheng Quan Toh, et al.
Published: (2020-10-01)

Measurement of neutralizing serum antibodies of patients vaccinated with human papillomavirus L1 or L2-based immunogens using furin-cleaved HPV Pseudovirions.
by: Joshua W Wang, et al.
Published: (2014-01-01)

Identification of the neutralizing epitopes of Merkel cell polyomavirus major capsid protein within the BC and EF surface loops.
by: Maxime J J Fleury, et al.
Published: (2015-01-01)

Serology for human papillomavirus
by: Coursaget Pierre
Published: (2003-01-01)

Thiol-reactive reagents inhibits intracellular trafficking of human papillomavirus type 16 pseudovirions by binding to cysteine residues of major capsid protein L1
by: Hagiwara Ken'ichi, et al.
Published: (2007-10-01)

Serology for human papillomavirus Serología para el virus del papiloma humano
by: Pierre Coursaget
Published: (2003-01-01)

Human papillomaviruses and cancer in Uganda.
by: Newton, R, et al.
Published: (2004)

Ovarian cancer gene therapy using HPV-16 pseudovirion carrying the HSV-tk gene.
by: Chien-Fu Hung, et al.
Published: (2012-01-01)

Mechanisms regulating expression of the HPV 31 L1 and L2 capsid proteins and pseudovirion entry
by: Hindmarsh Patrick L, et al.
Published: (2007-02-01)

Optimization of SARS-CoV-2 Pseudovirion Production in Lentivirus Backbone With a Novel Liposomal System
by: Gokulnath Mahalingam, et al.
Published: (2022-03-01)

Inhibition of multidrug resistance by SV40 pseudovirion delivery of an antigene peptide nucleic acid (PNA) in cultured cells.
by: Benjamin Macadangdang, et al.
Published: (2011-03-01)

Comparative Analysis of Differential Cellular Transcriptome and Proteome Regulation by HIV-1 and HIV-2 Pseudovirions in the Early Phase of Infection
by: Tamás Richárd Linkner, et al.
Published: (2023-12-01)

Merkel Cell Polyomavirus Strains in Patients with Merkel Cell Carcinoma
by: Antoine Touzé, et al.
Published: (2009-06-01)

Assays for the Evaluation of the Immune Response to Marburg and Ebola Sudan Vaccination—Filovirus Animal Nonclinical Group Anti-Marburg Virus Glycoprotein Immunoglobulin G Enzyme-Linked Immunosorbent Assay and a Pseudovirion Neutralization Assay
by: Thomas L. Rudge, et al.
Published: (2022-07-01)

PSGL-1 Inhibits the Incorporation of SARS-CoV and SARS-CoV-2 Spike Glycoproteins into Pseudovirions and Impairs Pseudovirus Attachment and Infectivity
by: Sijia He, et al.
Published: (2020-12-01)

Role of L2 cysteines in papillomavirus infection and neutralization
by: Karanam Balasubramanyam, et al.
Published: (2009-10-01)

VLPs displaying a single L2 epitope induce broadly cross-neutralizing antibodies against human papillomavirus.
by: Ebenezer Tumban, et al.
Published: (2012-01-01)

Serological cross-reactivity between Merkel cell polyomavirus and two closely related chimpanzee polyomaviruses.
by: Jérôme T J Nicol, et al.
Published: (2014-01-01)

Seroprevalence and Cross-reactivity of Human Polyomavirus 9
by: Jérôme T.J. Nicol, et al.
Published: (2012-08-01)

Anti-spike, Anti-nucleocapsid and Neutralizing Antibodies in SARS-CoV-2 Inpatients and Asymptomatic Individuals
by: Etienne Brochot, et al.
Published: (2020-10-01)

Cooperativity Enables Non-neutralizing Antibodies to Neutralize Ebolavirus
by: Katie A. Howell, et al.
Published: (2017-04-01)

Subcritical Instabilities in Neutral Fluids and Plasmas
by: Maxime Lesur, et al.
Published: (2018-11-01)

Antibody neutralization of HIV-1.
by: Poignard, P, et al.
Published: (1996)

Mechanisms of virus neutralization by antibody.
by: Klasse, P, et al.
Published: (2001)

Neutralization of HIV-1 by antibody.
by: Sattentau, Q
Published: (1996)

Neutralizing antibodies in convalescent patients
by: Uhl, LFK, et al.
Published: (2020)

Neutralizing antiviral antibody responses.
by: Zinkernagel, R, et al.
Published: (2001)

Human antibodies that slow erythrocyte invasion potentiate malaria-neutralizing antibodies
by: Alanine, DGW, et al.
Published: (2019)

Characterization of neutralizing epitopes within the major capsid protein of human papillomavirus type 33
by: Sapp Martin, et al.
Published: (2006-10-01)

Advances on two serological assays for human papillomavirus provide insights on the reactivity of antibodies against a cross-neutralization epitope of the minor capsid protein L2
by: Filipe Colaco Mariz, et al.
Published: (2023-11-01)

Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers
by: Elise Landais, et al.
Published: (2018-09-01)

Engineering Venom’s Toxin-Neutralizing Antibody Fragments and Its Therapeutic Potential
by: Larissa M. Alvarenga, et al.
Published: (2014-08-01)

Neutralizing Antibody Therapeutics for COVID-19
by: Aeron C. Hurt, et al.
Published: (2021-04-01)

Neutralizing antibodies for orthobunyaviruses in Pantanal, Brazil.
by: Alex Pauvolid-Corrêa, et al.
Published: (2017-11-01)

The Effects of Somatic Hypermutation on Neutralization and Binding in the PGT121 Family of Broadly Neutralizing HIV Antibodies
by: Sok, Devin, et al.
Published: (2014)

Aspergillus fumigatus secretes a protease(s) that displays in silico binding affinity towards the SARS-CoV-2 spike protein and mediates SARS-CoV-2 pseudovirion entry into HEK-293T cells
by: Nozethu Mjokane, et al.
Published: (2024-03-01)